POST Online Media Lite Edition



 

Topic: ASTRAZENECA

292 results were found.

AstraZeneca to acquire EsoBiotec for up to $1 billion - March 21, 2025

AstraZeneca to buy Fusion Pharma for $2 billion in cash - March 19, 2024

AstraZeneca to buy Amolyt Pharma - March 19, 2024

AstraZeneca to acquire Amolyt Pharma for $1.05 billion - March 14, 2024

AstraZeneca plans £650 million investment in UK - March 7, 2024

AstraZeneca's Voydeya treatment recommended for EU approval - February 26, 2024

AstraZeneca completes $1.1 billion acquisition of Icosavax - February 20, 2024

AstraZeneca Q$ profit increased to $960 million - February 8, 2024

AstraZeneca, Sanofi's RSV treatment approved in China - January 2, 2024

AstraZeneca aquires Gracell Biotechnologies for up to $1.2 billion - December 28, 2023

AstraZeneca gets FDA green light for nerve disease treatment - December 22, 2023

AstraZeneca to acquire Icosavax in $1.1b deal - December 13, 2023

AstraZeneca Q3 revenues $11.5b - November 10, 2023

AstraZeneca’s Tagrisso plus chemotherapy for lung cancer patients granted Priority Review in U.S. - October 17, 2023

AstraZeneca's Alexion in $1 bln deal for Pfizer gene therapies - July 28, 2023

AstraZeneca Q2 sales up 17 percent - July 28, 2023

AstraZeneca signs $2 bln agreement with Quell to develop cell therapies - June 9, 2023

AstraZeneca Q1 profit increased - April 27, 2023

AstraZeneca Q4 revenue increased 25% - February 9, 2023

Capitainer announces collaboration with AstraZeneca - January 30, 2023

AstraZeneca to buy CinCor Pharma in $1.8 billion deal - January 9, 2023

AstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDA - January 6, 2023

AstraZeneca to acquire Neogene Therapeutics for up to $320 mln - November 29, 2022

EMA panel signs off on AstraZeneca Imfinzi's use in biliary tract cancer - November 11, 2022

Alexion, AstraZeneca Rare Disease to acquire LogicBio Therapeutics - October 4, 2022

AstraZeneca's Tezpire approved in EU for severe asthma - September 21, 2022

Ukraine stops deliveries of AstraZeneca, Moderna coronavirus vaccines - September 20, 2022

AstraZeneca's COVID-19 treatment Evusheld recommended for authorization in EU - September 16, 2022

AstraZeneca revenue $10.8bn - July 29, 2022

AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion - July 5, 2022

AstraZeneca's COVID Vaxzevria gets approval in EU as booster dose - May 23, 2022

AstraZeneca wins license to make and sell COVID antibodies - May 17, 2022

AstraZeneca Q1 core profit rises 60% - April 29, 2022

Britain approves AstraZeneca's antibody-based COVID therapy - March 17, 2022

Australia provisionally approves AstraZeneca's COVID-19 vaccine as booster dose - February 10, 2022

AstraZeneca FY21 revenue up 41% - February 10, 2022

AstraZeneca vaccine booster shot effective against Omicron - December 23, 2021

FDA grants emergency use for AstraZeneca's COVID-19 preventative - December 9, 2021

Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca - December 2, 2021

EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in EU for 5-11 year olds - November 26, 2021

AstraZeneca Q3 revenue up 50% - November 12, 2021

AstraZeneca COVID-19 drug cocktail meets main goal in late stage trial - October 11, 2021

Vietnam to buy 400,000 AstraZeneca vaccines from Hungary - October 7, 2021

AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19 - October 5, 2021

AstraZeneca to invest $360m in advanced manufacturing facility in Ireland, create jobs - September 22, 2021

AstraZeneca, EU reach settlement on delivery of COVID-19 vaccine doses - September 3, 2021

AstraZeneca and Sputnik Light combination demonstrates high immunogenicity profile in clinical study - August 23, 2021

AstraZeneca's antibody drug prevents COVID-19 in high-risk groups - August 21, 2021

Russia approves trials of combined AstraZeneca/Sputnik V vaccine - July 27, 2021

Netherlands donates 745,000 doses of AstraZeneca abroad - July 20, 2021

Thailand to limit locally-manufactured AstraZeneca vaccine exports - July 15, 2021

Canada to donate nearly 18 million AstraZeneca doses to low and middle income countries - July 13, 2021

Thailand to mix Sinovac, AstraZeneca vaccines to increase protection - July 12, 2021

Netherlands allows Pfizer after first dose of AstraZeneca - July 7, 2021

AstraZeneca receives EU clearance for £27.5bn Alexion acquisition - July 6, 2021

Millions of Brits given AstraZeneca jab could be banned from Europe - July 2, 2021

Australian doctors granted indemnity for AstraZeneca COVID-19 vaccinations - June 29, 2021

Australia to phase out AstraZeneca vaccine from October - June 24, 2021

Vietnam buys 30 million AstraZeneca vaccine doses, wants its own homegrown vaccines - June 20, 2021

AstraZeneca must give 80.2m COVID-19 doses to EU by September end - June 18, 2021

Australia raises AstraZeneca safety age to 60 - June 17, 2021

AstraZeneca COVID-19 vaccine 92% effective against Delta (India) variant, antibody combination not so effective - June 15, 2021

Italy suspends AstraZeneca vaccine for under 60s - June 12, 2021

Taiwan gets 1.24 million doses of AstraZeneca vaccines from Japan - June 4, 2021

AstraZeneca appoints Aradhana Sarin as chief financial officer - June 4, 2021

Chile temporarily suspends Oxford-AstraZeneca vaccine shots for people under 45 - June 4, 2021

Indonesia declares suspended AstraZeneca vaccine batch safe to use - May 27, 2021

German scientist found solution to blood clots linked to AstraZeneca, Johnson & Johnson COVID-19 vaccine - May 27, 2021

EU seeks huge fine for AstraZeneca: 10 euros for each day of delay plus 10 million euros - May 26, 2021

Nipro, AstraZeneca sign COVID-19 vaccine deal for supply in Japan - May 26, 2021

UK regulator opens probe into AstraZeneca's Alexion purchase - May 25, 2021

Haiti approved AstraZeneca COVID-19 vaccine - May 25, 2021

Argentina sending Mexico material for 4 mln AstraZeneca doses - May 22, 2021

Japan approves Moderna, AstraZeneca COVID-19 vaccines - May 21, 2021

Malawi destroys 19,610 expired COVID-19 AstraZeneca vaccines - May 20, 2021

Denmark allows AstraZeneca and Johnson & Johnson vaccines to be given by private suppliers - May 20, 2021

Austria halts use of AstraZeneca COVID-19 vaccine - May 20, 2021

Indonesia suspends distribution of batch of AstraZeneca COVID-19 vaccine - May 16, 2021

Iran approves Italy-made AstraZeneca COVID-19 vaccine - May 14, 2021

Slovakia suspends AstraZeneca vaccine after death - May 13, 2021

Norway drops AstraZeneca vaccine - May 13, 2021

Ontario stops administering of first doses of AstraZeneca COVID-19 - May 12, 2021

Pakistan bars people under 40, those with allergies from taking AstraZeneca COVID-19 vaccine - May 11, 2021

EU: We didn't order AstraZeneca vaccine - May 9, 2021

Under-40s in UK to be offered alternative to AstraZeneca jab - May 8, 2021

Germany to allow AstraZeneca COVID-19 vaccine for all adults - May 7, 2021

Spain extends AstraZeneca COVID vaccine dose gap to 4 months - May 1, 2021

AstraZeneca Q1 net profit $1.56 billion - April 30, 2021

EU legal case against AstraZeneca begins in Brussels court - April 28, 2021

White House: U.S. would share its entire supply of AstraZeneca COVID-19 vaccine with other countries - April 27, 2021

EU sues AstraZeneca for non-delivery of vaccines - April 26, 2021

Bangladesh halts administering first dose of AstraZeneca COVID jabs - April 26, 2021

AstraZeneca vaccines sent to Mexico from Baltimore plant safe - April 25, 2021

EU looks to sue AstraZeneca over delivery shortfall - April 22, 2021

Denmark loans 55,000 AstraZeneca vaccines to Schleswig-Holstein - April 22, 2021

Denmark negotiating exchange of AstraZeneca vaccines - April 22, 2021

India's Serum institute to sell AstraZeneca vaccine to private hospitals - April 21, 2021

AstraZeneca could have COVID-19 vaccine against South Africa variant by end of 2021 - April 18, 2021

Uganda to import more AstraZeneca vaccines in May - April 18, 2021

Emergency Use Listing granted to AstraZeneca and Serum Institute of India - April 16, 2021

No decision made yet on future contracts with AstraZeneca, Johnson & Johnson, French minister says - April 16, 2021

Czech Republic: We'll take Denmark’s unwanted AstraZeneca COVID vaccine - April 15, 2021

Denmark first country to completely stop using AstraZeneca vaccine - April 14, 2021

Spain: 63% of people don't want AstraZeneca vaccine - April 11, 2021

Half of weekly AstraZeneca vaccine deliveries to EU delayed - April 11, 2021

EU: All AstraZeneca COVID vaccines from Netherlands to stay in Europe - April 9, 2021

France to recommend mRNA COVID-19 shots as second dose for some after AstraZeneca - April 9, 2021

Italy recommends AstraZeneca vaccine only for over 60 - April 9, 2021

German regulator sticks to age limit for AstraZeneca COVID shot - April 8, 2021

Under 30s in UK to be offered alternative to AstraZeneca vaccine - April 8, 2021

EMA finds possible link between AstraZeneca COVID-19 vaccine and very rare cases of unusual blood clots - April 7, 2021

AstraZeneca vaccine trial on children halted - April 7, 2021

EMA official: There is link between AstraZeneca vaccine and thrombosis - April 6, 2021

AstraZeneca vaccine renamed Vaxzevria - April 3, 2021

Netherlands halts AstraZeneca shots for under 60 - April 3, 2021

Germany restricts use of AstraZeneca vaccine - March 31, 2021

8 Canadian provinces suspend AstraZeneca vaccine for people under age 55 - March 31, 2021

Spain removes age limits on AstraZeneca, Johnson & Johnson vaccines - March 31, 2021

Two Berlin hospitals pause AstraZeneca vaccine - March 30, 2021

Canada suspends AstraZeneca vaccine for adults 55 and under - March 30, 2021

Finland resumes use of AstraZeneca COVID-19 vaccine for over-65s - March 30, 2021

Increase in manufacturing capacity for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna - March 27, 2021

Zambia settles for AstraZeneca, Johnson & Johnson COVID-19 vaccines - March 27, 2021

Norway stops AstraZeneca vaccine for another three weeks, 479 serious side effects reported - March 26, 2021

Macron backs EU decision to block AstraZeneca exports - March 26, 2021

Denmark suspends AstraZeneca COVID-19 vaccine for another three weeks - March 25, 2021

AstraZeneca says vaccine doses in Italy not stockpile - March 25, 2021

Update: AstraZeneca U.S. data vaccine has 76 percent overall efficacy - March 25, 2021

Officials found 29m AstraZeneca jabs hidden in Italy - March 24, 2021

Merkel backs EU chief's AstraZeneca export ban threat - March 23, 2021

U.S.: We need more data on AstraZeneca COVID-19 vaccine - March 23, 2021

British virus variant accounts for 80% of cases in Poland, AstraZeneca vaccine to be enforced - March 22, 2021

Regulator approves Australian-manufactured AstraZeneca COVID-19 vaccines - March 22, 2021

U.S. study on 32,449 people shows AstraZeneca vaccine offers 100% protection against severe disease - March 22, 2021

Finland suspends use of AstraZeneca vaccine despite EMA recommendation - March 20, 2021

Europe to resume AstraZeneca vaccination - March 19, 2021

Europe's top health agency about AstraZeneca COVID-19 vaccine: Benefits still outweigh risks - March 18, 2021

WHO: We recommend that vaccinations with AstraZeneca vaccine to continue - March 18, 2021

Europe announces vaccine passport plan, could seize AstraZeneca factories - March 17, 2021

Norwegian professor: It's reasonable to believe in connection between AstraZeneca jab and blood clots - March 17, 2021

Lithuania temporarily suspends use of AstraZeneca COVID-19 vaccine - March 17, 2021

Sweden discovers new serious side effect of AstraZeneca COVID-19 vaccine - March 16, 2021

Venezuela: AstraZeneca COVID-19 vaccine will not be used here - March 16, 2021

AstraZeneca increases COVID-19 vaccine doses to U.S. - March 16, 2021

Top European medicine body continues investigation of AstraZeneca COVID-19 vaccine and blood clots - March 15, 2021

Germany, France, Spain and Italy suspend use of AstraZeneca vaccine - March 15, 2021

Netherlands reports 10 cases of possible thrombosis after AstraZeneca vaccine - March 15, 2021

Ireland's advisory committee recommends suspension of AstraZeneca COVID-19 vaccine - March 14, 2021

WHO: No reason to stop using AstraZeneca vaccine - March 12, 2021

Bulgaria suspends all vaccinations with AstraZeneca - March 12, 2021

Romania and Thailand suspends AstraZeneca vaccine, Germany and France not worried - March 12, 2021

Denmark suspends AstraZeneca COVID-19 vaccine - March 11, 2021

Papua New Guinea PM about approved AstraZeneca COVID-19 vaccine: First people, then me - March 9, 2021

Italy follows France, Germany in giving OK to AstraZeneca vaccine for elderly - March 9, 2021

Iran to import over 3m doses of AstraZeneca COVID-19 vaccine from South Korea - March 8, 2021

Austria suspends AstraZeneca vaccine batch amid death investigation - March 8, 2021

Italy blocks export of AstraZeneca COVID vaccine to Australia, EU agrees - March 4, 2021

Malaysia approves AstraZeneca, Sinovac vaccines, Sputnik V under examination for approval - March 3, 2021

Canada to receive 2m doses of AstraZeneca’s vaccine manufactured by Serum Institute of India - February 28, 2021

People in Europe want Pfizer vaccine instead of AstraZeneca; big cut in supply ahead - February 23, 2021

South Africa offers AstraZeneca jabs to African Union - February 18, 2021

Africa not 'walking away' from AstraZeneca COVID-19 vaccine, CDC says - February 11, 2021

AstraZeneca Q4 profit surges - February 11, 2021

WHO panel says okay to use AstraZeneca vaccine - February 10, 2021

Azerbaijan to conduct world’s first clinical trials of Sputnik V and AstraZeneca combination - February 10, 2021

South Africa suspends launch of Oxford/AstraZeneca vaccine - February 8, 2021

UK Oxford AstraZeneca vaccine effective against variant - February 6, 2021

Switzerland declines to authorise AstraZeneca vaccine over insufficient data - February 4, 2021

Norway will not offer AstraZeneca COVID-19 vaccine to people over 65 - February 4, 2021

Bangladesh sending Hungary 5,000 doses of Oxford/AstraZeneca coronavirus jab - February 3, 2021

French health body clears AstraZeneca COVID-19 vaccine for under 65 - February 3, 2021

Von der Leyen: AstraZeneca to increase vaccine supply, expand manufacturing capacity in Europe - February 1, 2021

Pakistan to get 17m doses of Oxford-AstraZeneca vaccine - January 31, 2021

Ministry: Brazil to receive 10-14 mln AstraZeneca vaccine doses starting mid-February - January 31, 2021

Kuwait approves emergency use of Astrazeneca-Oxford COVID-19 vaccine - January 30, 2021

EU approves AstraZeneca's COVID-19 vaccine, company published contract - January 29, 2021

AstraZeneca to produce 90 mln COVID-19 vaccine doses in Japan - January 29, 2021

Philippines approved AstraZeneca vaccine for emergency use - January 28, 2021

EU orders raid of AstraZeneca vaccine plant in Belgium - January 28, 2021

Chile approves emergency use of Oxford-AstraZeneca COVID-19 vaccine - January 28, 2021

AstraZeneca CEO: Vaccine contract is not a commitment. EU: Publish the contract - January 27, 2021

AstraZeneca chief executive Soriot says 'not selling EU doses to other countries' - January 27, 2021

AstraZeneca's reduced vaccine supply to EU not acceptable, says commissioner - January 26, 2021

Sri Lanka to receive first batch of Oxford-AstraZeneca vaccines on January 27, says president - January 25, 2021

UK emergency services trying to protect AstraZeneca vaccine factory from flooding - January 21, 2021

Brazil approves emergency use of Chinese Sinovac, AstraZeneca COVID-19 vaccines - January 18, 2021

Pakistan approves AstraZeneca coronavirus vaccine for emergency use - January 17, 2021

Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine - January 6, 2021

Mexico OKs AstraZeneca/Oxford coronavirus vaccine, expects to arrive in March - January 5, 2021

AstraZeneca: Atacand divestment to Cheplapharm in more than 70 countries completed - January 4, 2021

UK first to roll out AstraZeneca coronavirus vaccine - January 4, 2021

India approves Oxford-AstraZeneca vaccine - January 1, 2021

Maldives to acquire AstraZeneca vaccine, says minister - January 1, 2021

Britain approves AstraZeneca Oxford coronavirus vaccine - December 30, 2020

AstraZeneca to buy Alexion for $39bn - December 13, 2020

AstraZeneca to test combining coronavirus vaccine with Russian shot - December 11, 2020

AstraZeneca to sell Crestor rights in Europe - December 1, 2020

Thailand, Philippines signs supply deals for AstraZeneca coronavirus vaccine, Malaysia likes Pfizer - November 27, 2020

AstraZeneca’s mistake in coronavirus vaccine trials could halt approval - November 26, 2020

Philippines reports 1,392 new coronavirus cases, plans to buy 2m doses of vaccine from AstraZeneca - November 26, 2020

Oxford AstraZeneca coronavirus vaccine 70% effective - November 23, 2020

Trials for AstraZeneca's coronavirus treatment set to begin in UK - November 21, 2020

AstraZeneca Q3 profit more than doubles - November 5, 2020

Korea begins preliminary review of AstraZeneca's coronavirus vaccine candidate - October 27, 2020

AstraZeneca coronavirus vaccine trials resumed as FDA confirms safety - October 24, 2020

AstraZeneca vaccine trials resume in Japan - October 2, 2020

AstraZeneca's trial illnesses may not be due to coronavirus shot says Oxford University - September 17, 2020

AstraZeneca coronavirus vaccine study put on hold - September 9, 2020

Australia to receive first batch of AstraZeneca coronavirus vaccine in January 2021 - September 7, 2020

EU signs first deal with AstraZeneca to buy coronavirus vaccines - August 28, 2020

AstraZeneca doses first patient in coronavirus treatment trial - August 25, 2020

Sweden to buy 6 million coronavirus vaccine doses from AstraZeneca - August 21, 2020

AstraZeneca, Daiichi Sankyo in $1b oncology deal plus billions more - July 27, 2020

Brazil to produce AstraZeneca's experimental coronavirus vaccine - June 27, 2020

Japan, AstraZeneca to start talks on coronavirus vaccine supply - June 27, 2020

Pig trial of AstraZeneca's coronavirus vaccine shows promise with two shots - June 23, 2020

Spain likely to join European deal to buy coronavirus vaccine from AstraZeneca - June 16, 2020

AstraZeneca to supply Europe with up to 400m doses of Oxford vaccine at no profit - June 14, 2020

Gilead's stock rallies, AstraZeneca falls after Gilead said not interested in merger - June 8, 2020

AstraZeneca in informal talks with Gilead Sciences for potential merger - June 8, 2020

No vaccine yet but AstraZeneca has agreement for 400 million doses - May 21, 2020

AstraZeneca Q1 profit rises - April 29, 2020

AstraZeneca divests some drugs to Atnahs Pharma - March 2, 2020

AstraZeneca divests Movantik rights in $68 million deal - February 25, 2020

AstraZeneca profit falls - February 14, 2020

AstraZeneca to invest millions in Poland - January 23, 2020

AstraZeneca divests rights to Arimidex and Casodex for $181m upfront - December 20, 2019

AstraZeneca lost patent protection, will divests rights to Seroquel and Seroquel - December 3, 2019

AstraZeneca Q3 profit declines - October 24, 2019

AstraZeneca appoints Michel Demare to board - August 19, 2019

AstraZeneca Q1 profit surges on strong sales - April 26, 2019

AstraZeneca to pay Daiichi Sankyo up to $6.9 billion in cancer deal - March 30, 2019

AstraZeneca to raise $3.5bn for cancer collab, bond repayment - March 29, 2019

PharmaVentures to sell former AstraZeneca plant in UK - February 26, 2019

AstraZeneca pretax profit USD1.99 billion - February 14, 2019

Sobi buys rights to AstraZeneca infant drug for $1.5 bn upfront - November 13, 2018

AstraZeneca Q3 sales rose 8 percent - November 8, 2018

AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal for upfront $700 million - October 30, 2018

AstraZeneca Q2 profit declined to $350 million - July 26, 2018

Astrazeneca hoards drugs in preparation for Brexit - July 19, 2018

AstraZeneca Q1 total revenue down 4 percent - May 18, 2018

AstraZeneca Q4 profit down to $407 million - February 2, 2018

AstraZeneca forms China JV, submits Tagrisso application - November 27, 2017

AstraZeneca Q3 pre-tax profit up, product sales down - November 9, 2017

AstraZeneca, Merck in collaboration on cancer drug, will receive up to $8.5 billion - July 27, 2017

AstraZeneca adds nearly half a billion dollars as two deals go through - July 3, 2017

Astrazeneca agrees sale of migraine treatment to Grunenthal for $200m plus $102m - June 7, 2017

AstraZeneca appoints Nazneen Rahman as director - June 1, 2017

AstraZeneca Q1 net profit down, core EPS up - April 27, 2017

AstraZeneca Q4 earnings per share increased 93 percent - February 2, 2017

AstraZeneca completes sale of rights to Pfizer - December 23, 2016

AstraZeneca: Tagrisso could replace chemo for some - December 6, 2016

AstraZeneca director Jean-Philippe Courtois to step down - November 10, 2016

Astrazeneca revenue, core operating profit down - November 10, 2016

AstraZeneca director Cornelia Bargmann to step down - September 29, 2016

AstraZeneca sells anaesthetic rights to Aspen - September 1, 2016

Pfizer to buy antibiotics business from AstraZeneca - August 24, 2016

AstraZeneca goes from profit to Q2 $30 million loss - July 28, 2016

AstraZeneca mulling making a bid for America's Medivation - July 11, 2016

AstraZeneca signs up to $1 billion deal with LEO Pharma - July 1, 2016

U.S. to AstraZeneca: Your flu vaccine data is not good - June 23, 2016

AstraZeneca in $770 million deal with Aspen Group - June 9, 2016

AstraZeneca licenses Zurampic to Grünenthal for $230 million - June 3, 2016

AstraZeneca will keep its North America commercial HQ in Delaware - May 4, 2016

Sun Pharma and AstraZeneca India enter partnership in Type 2 diabetes - March 25, 2016

AstraZeneca jumps to net profit of $808 million in Q4 - February 4, 2016

GSK, AstraZeneca, Johnson & Johnson join forces with UK universities - January 26, 2016

AstraZeneca to acquire 55% of of Acerta for upfront payment of $2.5 billion - December 17, 2015

AstraZeneca boosts respiratory unit with $575 million Takeda deal - December 16, 2015

AstraZeneca and Sanofi to share chemical compounds - November 23, 2015

AstraZeneca sells U.S. drug rights to Perrigo for $380 million - November 23, 2015

AstraZeneca lifts forecast, buys ZS Pharma for $2.7 billion - November 6, 2015

AstraZeneca buys factory in Boulder, Colorado - September 12, 2015

AstraZeneca appoints Sean Bohen as EVP - August 25, 2015

AstraZeneca Q2 revenue increased 2% at constant currency - July 30, 2015

Genzyme to pay AstraZeneca up to $300 million for Caprelsa - July 28, 2015

AstraZeneca sells Crohn's disease and ulcerative colitis medicine rights - July 9, 2015

AstraZeneca paid $135 million to FibroGen - June 30, 2015

Amgen to terminate partnership with AstraZeneca after suicidal ideation - May 23, 2015

AstraZeneca to invest in new biologics manufacturing facility in Sweden - May 19, 2015

AstraZeneca and PatientsLikeMe in global research collaboration - April 14, 2015

Nektar Therapeutics gets $100 million from AstraZeneca - April 3, 2015

AstraZeneca to appoint Cornelia Cori Bargmann as director - February 18, 2015

AstraZeneca to acquire rights to Actavis' respiratory portfolio - February 5, 2015

AstraZeneca proposes Ann Cairns for non-executive director - March 21, 2014

AstraZeneca CFO Simon Lowth to leave the company - July 15, 2013

AstraZeneca appoints EVP, global portfolio & product strategy - March 22, 2013

Martin Mackay and Tony Zook to leave AstraZeneca - January 16, 2013

Pascal Soriot appointed CEO of AstraZeneca - August 28, 2012

Martin Mackay to lead AstraZeneca's research and development organisation - May 27, 2010

AstraZeneca Appoints Graham Baker Vice President and CFO for North America - December 3, 2008

AstraZeneca appoints Rich Fante as president of its U.S. business - November 18, 2008


Back home